Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radiation Dose-Response Relationship. Found 15 abstracts

Doss M. Are We Approaching the End of the Linear No-Threshold Era?. J Nucl Med. 2018 Dec;59(12):1786-93.   PMCID: Letter
Luo W, Li J, Fourkal E, Fan J, Xu X, Chen Z, Jin L, Price R, Ma CM. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams. Phys Med Biol. 2008 Dec 21;53(24):7151-66.
Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys. 2007 Jul;68(3):682-9.
Little DJ, Kuban DA, Levy LB, Zagars GK, Pollack A. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology. 2003 Oct;62(4):707-13.
Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys. 2002 Oct;54(2):427-35.
Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002 Dec;54(5):1314-21.
Stobbe CC, Park SJ, Chapman JD. The radiation hypersensitivity of cells at mitosis. International Journal of Radiation Biology. 2002 Dec;78(12):1149-57.
Wang L, Yorke E, Desobry G, Chui CS. Dosimetric advantage of using 6 MV over 15 MV photons in conformal therapy of lung cancer: Monte Carlo studies in patient geometries. J Appl Clin Med Phys. 2002 Jan;3(1):51-9.
Hanks GE, Hanlon AL, Horwitz EM. Evidence for cure of 'young' men with prostate cancer. Oncology (Huntingt). 2001 May;15(5):563-7; discussion 571-4.
Hanks GE. Conformal radiotherapy for prostate cancer. Ann Med. 2000 Feb;32(1):57-63.
Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Price RA, Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 2000 Mar;46(4):823-32.
Kestin LL, Jaffray DA, Edmundson GK, Martinez AA, Wong JW, Kini VR, Chen PY, Vicini FA. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 2000 Jan;46(1):35-43.
Pinover WH, Hanlon AL, Horwitz EM, Hanks GE. Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer. Int J Radiat Oncol Biol Phys. 2000 Jun;47(3):649-54.
Movsas B, Barrows MC, Steinberg SM, Middleton LP, Okunieff P, Jaffe ES, Epstein AH. Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's disease. Radiat Oncol Investig. 1998 Jan;6(5):216-25.
Herold D, Hanks G, Movsas B, Hanlon A. Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values < 10 ng/ml. Radiat Oncol Investig. 1997 Jan;5(1):15-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radiation Dose-Response Relationship

Radiation Dose-Response Relationship radiotherapy Human Male Prostatic Neoplasms Conformal Radiotherapy methods Aged Radiotherapy Dosage blood pathology Follow-Up Studies Treatment Outcome Prostate-Specific Antigen radiation effects Middle Age Neoplasm Staging etiology Regression Analysis Radiometry Female Computer-Assisted Radiotherapy Planning Adult US Gov't Support-PHS psychology Prognosis 80 and over Aged Questionnaires Predictive Value of Tests Time Factors Risk Assessment Prospective Studies Proportional Hazards Models Rectum therapeutic use X-Ray Computed Tomography radiography prevention & control Photons Gastrointestinal Hemorrhage Monte Carlo Method Non-US Gov't Support Quality of Life physiology Comparative Study statistics & numerical data adverse effects Retrospective Studies Psychological Sexual Dysfunctions statistics & Actuarial Analysis High-Energy Radiotherapy Diarrhea DNA Oxygen Hodgkin Disease LNT model Segmental Mastectomy numerical data Lung Neoplasms Pennsylvania Cell Cycle metabolism Mutation Treatment Failure Drug Dose-Response Relationship Comet Assay NCRP commentary no 27 Linear Models Intestines Age Factors epidemiology Risk Factors radiation hormesis pharmacology surgery Multivariate Analysis Biological Tumor Markers Lymphatic Metastasis Hematuria Breast Neoplasms Chromatin Hydroxyl Radical Local Neoplasm Recurrence Recurrence Immune System mortality Mediastinum Tissue Distribution Adjuvant Radiotherapy Impotence Kinetics Radiation-Induced Neoplasms Urinary Incontinence Radiation Tolerance Incidence DNA Damage Dimethyl Sulfoxide Pilot Projects Patient Satisfaction Biological Models Radiation Protection Iridium Radioisotopes Emission-Computed Tomography-Single-Photon Brachytherapy Intensity-Modulated Radiotherapy Lasers Bladder Analysis of Variance Defecation Mitosis Radiation Dosage Algorithms Neoplasms Adenocarcinoma Hormesis Cohort Studies Adolescent Cultured Tumor Cells Protons BEIR VII report Interphase
Last updated on Wednesday, February 05, 2020